Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F6F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,388
Award facts
- Contract value 100% obligated
- $24,387.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,387.67 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Dupixent 300 mg/2 ml pens (2 ml vials), with performance completion scheduled for January 9, 2026. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. The place of performance is listed as Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs. This award is issued as a child contract under the parent entity Cencora, Inc., which does business as AmerisourceBergen.
This delivery order is executed under the larger Indefinite Delivery Contract vehicle held by Cencora, Inc. with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical commodities across multiple therapeutic domains, with contract awards ranging from minimal to substantial values depending on specific medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F5F6F?
SPE2DR26F5F6F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F5F6F worth?
The government has obligated $24,388 on SPE2DR26F5F6F.
Is contract SPE2DR26F5F6F an order under another contract?
Yes. SPE2DR26F5F6F is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F6F competed?
The extent of competition for SPE2DR26F5F6F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award